Treatment

Disinfection requires verified exposure

Work through chlorine chemistry, effective contact time, UV validation and the relationship between treatment and distribution protection.

Engineering chapter5 min readEdition: 25 September 2026

Start with the organism and the barrier objective

Disinfection inactivates microorganisms; physical separation removes them. A supply system usually needs a combination suited to its source hazards. Organisms differ substantially in susceptibility, so “disinfected” is incomplete without identifying the process, target organisms and operating conditions.

A chlorine residual at a sampling point does not prove that every parcel received the required primary disinfection exposure. Equally, a validated UV reactor does not provide a lasting disinfectant residual throughout a network. Separate the objective of primary inactivation from the objective of maintaining distribution-system protection. Link both to the source assessment and the other validated barriers.

Interpret chlorine chemistry and demand

HOCl ⇌ H⁺ + OCl⁻; fraction as HOCl ≈ 1/[1 + 10^(pH − pKa)]

The simplified equilibrium expression uses pKa approximately 7.5 near ordinary water-treatment temperatures; the value varies with conditions.

Free chlorine includes both hypochlorous acid and hypochlorite ion. Their proportions depend strongly on pH, and their disinfection effectiveness differs. At pH equal to pKa, the simplified expression gives equal fractions. At one pH unit higher it gives about 9% HOCl. This is a chemistry illustration, not a proposal to change plant pH without considering stability and treatment requirements.

Chlorine reacts with constituents in the water. Applied dose, immediate demand and measured residual are different quantities. Residual also changes with elapsed time. A nominal feed rate cannot substitute for validated residual measurements. Product strength can change during storage, and results must be expressed on a consistent chlorine basis.

Use effective contact time, not just tank volume

Nominal detention = V/Q; CT = C × T₁₀

C is an appropriate measured disinfectant residual in mg/L and T₁₀ an effective contact time in minutes; CT is mg·min/L. The credited calculation method must match the validation basis.

T₁₀ represents the contact time exceeded by about 90% of the water in the relevant tracer interpretation. Poor inlet and outlet arrangements can produce short-circuiting even in a large tank. Water level, flow, mixing and baffling influence the effective exposure. A tracer study or an accepted hydraulic assessment is therefore more informative than volume divided by flow alone.

In a teaching example, a contact zone contains 600 m³ at a flow of 300 m³/hour. Nominal detention is 120 minutes. If an applicable tracer assessment gives T₁₀ = 45 minutes and the adopted conservative residual is 0.6 mg/L, the calculated CT is 27 mg·min/L. Using 120 minutes instead would produce 72 mg·min/L, over 2.6 times as much credited exposure. Neither number establishes compliance without a target appropriate to the organism, temperature, pH and required reduction.

What kinetic equations can and cannot establish

dN/dt = −kN; ln(Nt/N₀) = −kt; LRV = kt/ln(10)

This first-order model assumes a constant effective inactivation rate. A concentration-dependent form may use k = λCⁿ.

The equations explain why both concentration and time matter. Real systems can exhibit changing residual, shielding, aggregation and non-ideal kinetics. A laboratory coefficient cannot automatically be transferred to full-scale operation or another organism. Where residual changes materially through a process, consider the appropriate segment-based or integrated exposure method accepted for that system.

A simple decay model is useful for understanding sensitivity, but it cannot replace challenge testing, accepted validation evidence or operational monitoring. Treat the calculated number as part of a demonstrated barrier argument, not as an isolated proof.

Compare disinfectants by their function

Different processes solve different parts of the problem
ProcessPlanning roleConditions to resolve
Free chlorinePrimary treatment for susceptible organisms and a distribution residual.Demand, pH, effective contact time, decay and by-products. Practical chlorination is not a reliable Cryptosporidium barrier.
ChloraminationA more persistent secondary residual in suitable systems.Formation control, nitrification, residual monitoring and compatibility when sources are blended.
Ultraviolet lightInactivation within a validated reactor.Flow, UV transmittance, lamp output, fouling and the validated operating envelope; no lasting residual.
OzoneStrong oxidation and disinfection within a contact process.Transfer efficiency, exposure, off-gas treatment and relevant by-products; no durable distribution residual.

For UV, lamp electrical power divided by flow is not a complete dose validation method. Reactor hydraulics and the distribution of UV exposure matter. UV transmittance changes how effectively light penetrates the water, so a reactor operating at the same flow can provide a different treatment outcome when source quality changes.

Protect disinfection while managing by-products

Organic precursors, bromide where relevant, oxidant dose, pH, temperature and residence time can affect by-product formation. Investigate precursor removal, process sequence and network residence time within an integrated assessment. Do not solve a by-product concern by allowing an unverified microbial barrier.

Use representative and adverse conditions to establish the operating envelope. A higher flow can reduce contact time, low storage level can reduce active volume, and poor filtered quality can change treatment effectiveness. These conditions can coincide during a peak-demand event, which is why nominal design capacity is not necessarily dependable disinfected output.

Make the response part of the design

  1. Define the target reduction and the validated envelope for each credited process.
  2. Identify the measurements that show the process remains inside that envelope, including data-quality checks.
  3. Specify how loss of dose, flow measurement, UV output or other critical evidence is detected.
  4. Demonstrate diversion, shutdown, hold or other approved responses, including their response times and available storage.
  5. Keep validation evidence distinct from routine monitoring and final-water verification.

The treatment assessment should state the reliable output when a train, monitor or chemical supply is unavailable. Continue to the barrier framework and distribution water quality.

Sources & further reading

Source findings are distinguished from editorial interpretation. Apply current local criteria and project evidence when making engineering decisions.